Swindled by Substandard Drugs

The rise of effective medications saw global malaria deaths drop an estimated 60% from 2000-2015—but markets flooded with fake chloroquine and artemisinin are slowing progress against the disease in the hardest-hit African countries, write the University of Canberra’s Jackson Thomas and colleagues.

200,000 preventable deaths occur annually due to faulty anti-malarials, many originating in India, China, Hong Kong and Turkey, they write. And some of the world’s poorest patients are paying out of pocket for these fake, substandard or degraded drugs, commanding repeat treatments that cost sub-Saharan African patients and health systems $38.5 million a year, according to the WHO.

The Conversation

Comments +

0 comments

Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top